Literature DB >> 19588029

Polypharmacy in psychiatric out-patient practice in northern Nigeria.

A B Adeponle1, A O Obembe, S O Adeyemi, G T Suleiman.   

Abstract

OBJECTIVE: To describe and analyze patterns of polypharmacy among psychiatric outpatients in northern Nigeria and identify predictors of psychotropic polypharmacy.
METHOD: A cross-sectional study, using chart review of new patients at out-patient clinics of two regional psychiatric hospitals in northern Nigeria,measuring rates, patterns and predictors of psychotropic polypharmacy.
RESULTS: A total of 278 patients were seen, of whom 92%were given two or more psychotropic agents.The pattern of psychotropic polypharmacy revealed that total, multi-class and adjunctive polypharmacy rates were high, while augmentation and same class polypharmacy rates were low. Age of respondent and diagnosis were the factors associated with total polypharmacy.
CONCLUSION: The complex interplay of factors influencing physician prescription practices requires that a more pragmatic approach be adopted in efforts to curtail polypharmacy practice, rather than a wholesale, absolute condemnation of the practice.

Entities:  

Year:  2007        PMID: 19588029

Source DB:  PubMed          Journal:  Afr J Psychiatry (Johannesbg)


  10 in total

1.  Prevalence and correlates of antipsychotic polypharmacy among outpatients with schizophrenia attending a tertiary psychiatric facility in Nigeria.

Authors:  Nosa Godwin Igbinomwanhia; Sunday Osasu Olotu; Bawo Onesirosan James
Journal:  Ther Adv Psychopharmacol       Date:  2016-10-13

2.  Attitude and preferences towards oral and long-acting injectable antipsychotics in patients with psychosis in KwaZulu-Natal, South Africa.

Authors:  Krishanand R Roopun; Andrew Tomita; Saeeda Paruk
Journal:  S Afr J Psychiatr       Date:  2020-07-27       Impact factor: 1.550

Review 3.  Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review.

Authors:  Michele Fornaro; Domenico De Berardis; Ann Sarah Koshy; Giampaolo Perna; Alessandro Valchera; Davy Vancampfort; Brendon Stubbs
Journal:  Neuropsychiatr Dis Treat       Date:  2016-03-31       Impact factor: 2.570

4.  Prevalence of Antipsychotic Polypharmacy and Associated Factors among Outpatients with Schizophrenia Attending Amanuel Mental Specialized Hospital, Addis Ababa, Ethiopia.

Authors:  Siranesh Tesfaye; Nigussie Debencho; Teresa Kisi; Minale Tareke
Journal:  Psychiatry J       Date:  2016-01-24

5.  Polypharmacy among children and adolescents with psychiatric disorders in a mental referral hospital in Botswana.

Authors:  Anthony A Olashore; Ambrose Rukewe
Journal:  BMC Psychiatry       Date:  2017-05-10       Impact factor: 3.630

6.  Prescribing pattern of psychotropic medications in child psychiatric practice in a mental referral hospital in Botswana.

Authors:  Anthony Olashore; James Ayugi; Philip Opondo
Journal:  Pan Afr Med J       Date:  2017-02-21

7.  Antipsychotic Use Pattern in Schizophrenia Outpatients: Correlates of Polypharmacy.

Authors:  Esra Yazici; Ali S Cilli; Ahmet B Yazici; Hayriye Baysan; Mustafa Ince; Sukriye Bosgelmez; Serkan Bilgic; Betul Aslan; Atila Erol
Journal:  Clin Pract Epidemiol Ment Health       Date:  2017-08-11

8.  Correlates of Psychotropic Polypharmacy in outpatient psychiatric clinics of two military tertiary hospitals in Saudi Arabia.

Authors:  Fares F Alharbi; Samar F Alharbi; Saleh Bin Salih; Khaled Al-Surimi
Journal:  J Family Community Med       Date:  2019 Sep-Dec

9.  Drug-related problems and associated factors among adult psychiatric inpatients in Northwest Ethiopia: Multicenter cross-sectional study.

Authors:  Ephrem Mebratu Dagnew; Mohammed Biset Ayalew; Gizework Alemnew Mekonnen; Alehegn Bishaw Geremew; Ousman Abubeker Abdela
Journal:  SAGE Open Med       Date:  2022-08-22

10.  Conformance to schizophrenia treatment guidelines in North West-Bank, Palestine: focus on antipsychotic dosing and polytherapy.

Authors:  Waleed M Sweileh; Jihad Bani Odeh; Sa'ed H Zyoud; Ansam F Sawalha; Manal S Ihbeasheh
Journal:  BMC Psychiatry       Date:  2013-07-01       Impact factor: 3.630

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.